CEO Bruce Dannenberg will be both chairing and speaking at the 15th Carbon Dioxide Utilization Summit 2020 in Orlando, Florida on February 26th and 27th. During the Emerging CO2 Utilization Technology in the Industry session Dannenberg will present Biological Carbon Dioxide Utilization (CDU) Technology for the Production of Low Cost Industrial Chemicals Utilizing Photosynthesis. Topics discussed will be:
- The Phytonix process directly reduces greenhouse gas (GHG) emissions at the rate of one metric tonne of CO2 per 138 gallons of biobutanol produced
- We expect our carbon negative process to produce cost leadership industrial chemicals at less than half the cost of the incumbent fossil producers
- Full global deployment could significantly reduce annual anthropogenic carbon dioxide emissions and help slow climate change to manageable levels.
For more information visit https://www.wplgroup.com/aci/event/co2-us/
ACI’s 10th Carbon Dioxide Utilization Summit follows on from a successful series of conferences focusing on the re-use of greenhouse gas CO2 and converting this into profitable sustainable materials. The two day conference brings together senior experts from various CO2 emitting industries discussing the sustainable, technological and commercial aspects of CO2 Utilization in North America and across the globe.
Mr. Bruce Dannenberg, Founder and CEO of Phytonix Corporation, has chaired and presented at this conference four consecutive years.
As Summit Chairman, Mr. Dannenberg provided opening and closing remarks each day, led meaningful discussions about the future of Carbon Dioxide Utilization, and presented current and upcoming Phytonix advancements.
For further details please visit: http://www.wplgroup.com/aci/event/co2-us/
Mr. Bruce Dannenberg, President and CEO of Phytonix Corporation, accepted an invitation to participate in and present at the one-day information-gathering meeting organized by The National Academies of Sciences, Engineering, and Medicine to answer the questions “What will the likely future products of biotechnology be over the next 5-10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology?”
Mr. Dannenberg provided the committee with important and valuable insights in regards to Phytonix’s breakthrough technology and it’s leadership approach for the utilization of both passive and active (proprietary) strategies and technology for the bio-safety guarded photobiological production of sustainable chemicals. This could provide a framework for future self-regulatory approaches and how these types of approaches might relate to appropriate future levels of mandated regulations.
To view Mr. Dannenberg’s presentation click the link below.